Therapeutic drug monitoring of rifampicin, isoniazid, and pyrazinamide in newly-diagnosed pulmonary tuberculosis outpatients in Denpasar area

Therapeutic drug monitoring of rifampicin, isoniazid, and pyrazinamide in newly-diagnosed pulmonary tuberculosis outpatients in Denpasar area

<p><strong>Background: </strong>Therapeutic drug monitoring (TDM) has the potency to enhance the therapeutic outcome of rifampicin, isoniazid, and pyrazinamide, the backbone of first-line anti-tuberculosis (TB) therapy. The implementation of TDM is understudied for newly-diagnosed...

Full description

Bibliographic Details
Main Authors:	Ida Ayu Alit Widhiartini, Made Agus Gelgel Wirasuta, Dewa Made Sukrama, Ida Bagus Ngurah Rai
Format:	Article
Language:	English
Published:	DiscoverSys 2019-04-01
Series:	Bali Medical Journal
Subjects:	low levels, first-line antituberculosis, tdm
Online Access:	https://balimedicaljournal.org/index.php/bmj/article/view/1304

Similar Items

Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics
by: Ana Santoveña-Estévez, et al.
Published: (2020-02-01)

The solubility enhancement and the stability assessment of rifampicin, isoniazid and pyrazinamide in aqueous media
by: Chen, Yu-Jen
Published: (2000)

Isoniazid, pyrazinamide and rifampicin content variation in split fixed-dose combination tablets.
by: Thomas Pouplin, et al.
Published: (2014-01-01)

Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
by: McIlleron, Helen
Published: (2014)

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
by: Amukoye, E, et al.
Published: (2021)

CYP2E1 genotype and transaminase level of tuberculosis patients receiving fixed dose combination of antituberculosis
by: I Gusti Ayu Artini, et al.
Published: (2017-08-01)

The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide
by: Lin HS, et al.
Published: (2016-03-01)

Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: Is anti-HCV a risk factor?
by: Lysandro Alsina Nader, et al.
Published: (2010-01-01)

Aplicações das técnicas de multiplexação por divisão no tempo à concentração remota de dados
by: José Roberto Castilho Piqueira
Published: (1982)

Aplicações das técnicas de multiplexação por divisão no tempo à concentração remota de dados
by: Piqueira, José Roberto Castilho
Published: (1982)

Theoretically Guided Analytical Method Development and Validation for the Estimation of Rifampicin in a Mixture of Isoniazid and Pyrazinamide by UV Spectrophotometer
by: Mohammad F. Khan, et al.
Published: (2017-04-01)

A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea
by: Choi R, et al.
Published: (2019-07-01)

Structure of Comorbidity of the Hepatobiliary System in Newly Diagnosed Pulmonary Tuberculosis Depending on Sensitivity Spectrum
by: L.D. Todoriko, et al.
Published: (2015-11-01)

“DENPASAR FESTIVAL” MENDUKUNG PARIWISATA BERBASIS EKONOMI KREATIF KOTA DENPASAR
by: Ni Made Dewiyanti, et al.
Published: (2017-02-01)

Effect of isoniazid preventive therapy on pulmonary tuberculosis activity in people living with HIV/AIDS at Wangaya hospital in Denpasar, Bali, Indonesia: a prospective cohort study
by: Ketut Suryana, et al.
Published: (2020-04-01)

ANTITUBERCULOSIS DRUG DOSAGE FORMS: RANGE, KEY BENEFITS AND PROSPECTS OF TECHNOLOGICAL IMPROVEMENT
by: M. E. Kim, et al.
Published: (2016-09-01)

Syntheses and evaluation of multicaulin and miltirone-like compounds as antituberculosis agents
by: Serdar Burmaoğlu, et al.
Published: (2017-01-01)

Unsuccessful antituberculosis medication treatment: A characteristic summarization in a suburban province with dense communities of Myanmar migrant worker in Bangkok Metropolitan Region, Thailand
by: Rujittika Mungmunpuntipantip, et al.
Published: (2019-01-01)

Incidence and characteristics of antituberculosis drug-induced hepatotoxicity in children: a preliminary study
by: Bina Akura, et al.
Published: (2009-12-01)

Antituberculosis Drug-induced Hepatotoxicity in Pediatric Tuberculosis
by: Vycke Yunivita, et al.
Published: (2019-10-01)

Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria
by: Samson E Isa, et al.
Published: (2016-01-01)

Contra-lateral paradoxical pleural effusion during antituberculous chemotherapy
by: Chopra Vishal, et al.
Published: (2008-01-01)

Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania.
by: Paolo Denti, et al.
Published: (2015-01-01)

COURT INTERPRETING AT DENPASAR COURT
by: Ida Ayu Made Puspani, et al.
Published: (2012-11-01)

Evaluation of the efficiency of antituberculosis vaccination in children born to HIV-infected women
by: N. I. Klevno, et al.
Published: (2016-11-01)

Congenital tuberculosis: a case report
by: Liana Consuelo Santana Vilarinho

The function of the thyroid gland in patients with multi-drug resistant tuberculosis
by: S. L. Matveyeva, et al.
Published: (2017-08-01)

Cholecalciferol for prophylaxis against antituberculosis therapy-induced liver disorders among naïve patients with pulmonary tuberculosis: A randomized, comparative study
by: Ahmad Farooq Alsayed Hasanain, et al.
Published: (2017-01-01)

Efectos adversos de consecuencia fatal por tratamiento con fármacos antituberculosos
by: Diana Carmela Rodriguez Hurtado, et al.
Published: (2002-10-01)

A study on comparative efficacy of anti tubercular chemoprophylaxis with 2 different regimens: 2 months of rifampicin and pyrazinamide and 6 months of daily isoniazid and rifampicin in HIV infected tuberculin reactors
by: Prasad BNBM
Published: (2006-01-01)

THE MAIN TENDENCIES OF OPTIMIZATION OF THE PASSIVE FIBER-OPTICAL NETWORKS PON
by: V. I. Kirillov, et al.
Published: (2019-06-01)

Leïomyosarcome de la prostate: Neoplasie rare
by: D. Basraoui, et al.
Published: (2012-03-01)

The Quality of Sputum Specimens as a Predictor of Isolated Bacteria From Patients With Lower Respiratory Tract Infections at a Tertiary Referral Hospital, Denpasar, Bali-Indonesia
by: Nyoman Sri Budayanti, et al.
Published: (2019-04-01)

Fenomena Media Periklanan terhadap Citra Kota Denpasar, Studi Kasus di Beberapa Persimpangan Jalan Utama Kota Denpasar
by: I Gusti Ngurah Bagus Kusuma Putra, et al.
Published: (2018-10-01)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

Hybrid switching : converging packet and TDM flows in a single platform
by: Parajuli, Roshan
Published: (2009)

Design and synthesis of antituberculosis compounds
by: ZOU Shun, et al.
Published: (2020-08-01)

Development of real-time pcr technology for the rapid detection of mycobacterium tuberculosis resistance to reserve antituberculosis drugs: fluoroquinolones, amikacin, and capreomycin
by: Yu. S. Alyapkina, et al.
Published: (2014-12-01)

Acute toxicity of pyridoxine hydrochloride-containing and noncontaining antituberculosis drugs (an experimental study)
by: K. I. Usov, et al.
Published: (2014-12-01)

Design, Synthesis and Study of Antibacterial and Antitubercular Activity of Quinoline Hydrazone Hybrids
by: T G Shruthi, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_k3e6gt1hlf3jqtqkgbsrgic575